ASBP Aspire Biopharma Holdings, Inc. (NASDAQ: ASBP) is attempting something relatively uncommon in the biotech space: ...

A UCLA-led international research collaboration has unveiled a new technology that may help scientists better understand how ...

As the threat of antibiotic resistance grows, a Swansea University academic has led the development of a novel technology capable of killing some of the most dangerous bacteria known to medicine—with ...

Taimei Technology, a leading AI-driven drug clinical development platform, made its first public appearance in South Korea at BioKorea 2026, drawing significant attention with its advanced AI-powered ...

DNA-encoded libraries have numerous advantages over traditional screening methods, including easy identification of compounds and the large quantity of compounds that can be screened simultaneously.

The pair will develop drug-digital therapeutic combinations as a singular product, thus sidestepping reimbursement hurdles linked to individually approved digital therapies.

New drug discovery is a critical step for improving patients' lives. First, researchers must identify molecules in the body's cells that help drive disease, as these are potential targets for new ...

AlphaFold, a transformative AI-driven tool developed by DeepMind, has revolutionized the field of structural biology by accurately predicting protein structures. This breakthrough holds significant ...

A team has developed a large-scale drug screening technique that can track target molecule behavior within cells. The researchers verified their technique by testing the epidermal growth factor ...

Natural product libraries play a foundational role in modern drug discovery, enabling the identification of bioactive compounds across therapeutic areas. These libraries are large, systematically ...

SEMINOLE COUNTY, Fla. — Today in Seminole County, Florida, a new technology named ‘Drug Alert AI’ was introduced to help address the drug crisis by identifying threats early before they become lethal.

Organoid screening has emerged as one of the most significant methodological advances in preclinical drug discovery, offering three-dimensional, self-organizing cellular architectures that more ...